Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Med.

Sec. Ophthalmology

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1569690

The Correlation Between Plasma Lactoferrin and Inflammatory Biomarkers in Type 2 Diabetes with Dry Eye Disease Patients

Provisionally accepted
Amani  AlhalwaniAmani Alhalwani1*Shatha  JambiShatha Jambi1Husain  AlalgumHusain Alalgum1Hawazen  ZarifHawazen Zarif1Sarah  AlshareefSarah Alshareef1Abrar  BabgiAbrar Babgi1RAWIAH  ABDULLAH ALSIARYRAWIAH ABDULLAH ALSIARY1Faisal  F. AlamriFaisal F. Alamri1Nizar  GustiNizar Gusti2Salwa  AlaidarousSalwa Alaidarous1
  • 1King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
  • 2King Abdulaziz University, Jeddah, Makkah, Saudi Arabia

The final, formatted version of the article will be published soon.

Background: Lactoferrin (LF) is a primarily protein derived from the degranulation of neutrophils in plasma, and has been identified as a potential biomarker for dry eye disease (DED) and type 2 diabetes patients (T2D). This study aims to investigate the correlation between plasma lactoferrin and other inflammatory biomarkers, such as lactoferrin to neutrophil ratio (LFNR) and glycosylated haemoglobin A1c (HbA1c), in type 2 diabetic patients with dry eye disease (T2D-DED). Method: This study was conducted at the Diabetes Center outpatient clinics at King Abdulaziz Medical City, Jeddah, Saudi Arabia. The study included two groups: 26 healthy individuals and 41 T2D-DED patients. The plasma samples were collected and analyzed in the hospital for laboratory routine tests for neutrophil, lymphocyte, C-reactive protein (CRP), glycosylated haemoglobin A1c (HbA1c), and albumin (ALB), and data were collected retrospectively from hospital medical records. The same plasma samples were tested for LF using an in-house enzyme-linked immunosorbent assay (ELISA). The plasma lactoferrin to neutrophil ratio (LFNR) and neutrophil to lymphocyte ratio (NLR) were calculated. All statistical analyses were performed using PRISM software , with a P-value< 0.05 were considered significant. Results: LF concentrations were found to be 1.10±1.0 µgmL-1 in T2D-DED patients and 0.5±0.4 µgmL-1 in healthy individuals. Inflammatory biomarkers, LF, CRP, HbA1C, and LFNR, showed elevated levels in patients with T2D-DED, with statistically significant differences groups compared to healthy individuals. Additionally, there was a significant positive correlation in T2D-DED patients between LF with LFNR in T2D-DED patients (P= 0.0001) and HbA1C with LF (P= 0.035). Conclusions: The study indicated that LF levels and other inflammatory biomarkers are elevated in patients with T2D-DED. There are significant positive correlations between LF and HbA1C, as well as LF and LFNR in T2D-DED patients, which differ from the correlations found in healthy individuals. This suggests that the diagnostic and prognostic relevance of these biomarkers depends on whether the disease is present.

Keywords: Lactoferrin (Lf), neutrophiles, ELISA, Dry eye disease (DED), Inflammation, type

Received: 01 Feb 2025; Accepted: 11 Jul 2025.

Copyright: © 2025 Alhalwani, Jambi, Alalgum, Zarif, Alshareef, Babgi, ALSIARY, Alamri, Gusti and Alaidarous. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Amani Alhalwani, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.